PCOS might not be an unfamiliar term to you and if it is, you’re in the right place. PMOS stands for Polyendocrine Metabolic Ovarian Syndrome and the name change didn’t come out of no where. To be honest, it’d been a long time coming.
At Scrub Life Cares, we talk about and normalize biological processes for girls and women to have better experiences in reproductive health–PMOS is no exception.
In May 2026, an international group of more than 50 patient and professional organizations announced a new name for the condition: polyendocrine metabolic ovarian syndrome, or PMOS. After more than a decade of collaboration from international clinicians, researchers, and people living with the condition, the research caught up.
It might seem like semantics, changing the name, but it’s more than that. It’s deeper.
Because for decades, polycystic ovary syndrome has encouraged us to think primarily about the ovaries. The change in name gives us the ability to think more broadly than the ovaries, because PMOS encompasses so much ore beyond ovarian dysfunction.
Why change the name?
Let’s start with the word that has probably caused the most confusion: polycystic.
Despite its name, ovarian cysts are not what define this condition, and the presence of ovarian cysts is not a requirement for diagnosis.
The name centers the ovaries, but it affects health beyond reproduction.
PMOS is associated with hormonal changes and can have implications for metabolic health, cardiovascular health, mental health, reproductive function, skin, and quality of life.
The new name—polyendocrine metabolic ovarian syndrome—reflects the variety of ways that this condition impacts the body. This is a huge shift that holds heavy value for healthcare professionals because what we call a condition influences what we look for.
PMOS is more than the ovaries
One of the things I appreciate about the shift to PMOS is that it gives healthcare professionals, clinicians, and educators a pathway to widen the conversation.
A patient may come into a primary care office because her periods are irregular.
Someone else may be seeking help for infertility.
Another woman may be concerned about acne or unwanted hair growth.
Another patient may have been told she has insulin resistance or elevated blood glucose.
These are a constellation of symptoms, but they become unclear when looking at them through such a narrow lens. However, PMOS encourages us to explore how these pieces and symptoms fit together in the grand scheme.
The 2023 international evidence-based guideline—now updated with PMOS terminology—emphasizes that the condition has important metabolic, cardiovascular, psychological, reproductive, and pregnancy-related considerations.
The perspective broadens, giving the medical field space to explore the spectrum of symptoms outside a box and women space to articulate symptoms as they present, without editing them to make sense. The symptoms didn’t make sense when the conversation was centered around the ovarian condition.
Symptoms don’t fit narrow definitions.
Hormones don’t exist in one room of the body.
Metabolism doesn’t exist in another part of the body.
Reproductive health doesn’t just have to do with the uterus and ovaries.
These systems are interconnected, and the sooner research catches up to that, the sooner our providers will be able to address women’s health holistically rather than categorically.
The metabolic side was the piece that was missing
The word metabolic in PMOS is there to create the holistic approach–not just for the women who experience PMOS through gaining weight.
That distinction is important–again–to bring the entire body into conversation.
Women who struggle with PMOS have an increased risk of impaired glucose tolerance and type 2 diabetes regardless of age or BMI. The international guideline recommends assessing glycemic status at diagnosis and periodically reassessing risk over time.
This is one area where healthcare professionals, clinicians, and educators alike can make a meaningful difference.
Weight gain won’t be the primary reason someone’s metabolic health is considered. Metabolic health isn’t synonymous with weight gain. Remember, we are widening the scope.
PMOS can present differently from one person to another. Some patients may have obvious metabolic concerns, and others may not present this way. Some may primarily present with reproductive symptoms, while others may seek care for hyperandrogenism or other concerns. What we are capturing now is the variety of ways that this condition can impact women.
That variability is part of the reason this condition can be difficult to recognize—and why individualized assessment matters.
What does this mean for nurses and other healthcare professionals?
The name change gives us an opportunity to ask better questions.
Not simply:
“Are your periods regular?”
But we get to look at patterns.
“What has your menstrual pattern looked like over time?”
We’re not just looking at ovaries, asking:
“Do you have ovarian cysts?”
Instead, we look for a combination of clinical features and ask what we see.
We are going beyond “What is your BMI?” and asking, “What does your overall metabolic health look like from a whole-body perspective?”
Depending on the clinical setting and scope of practice, healthcare professionals may need to consider questions related to:
- Menstrual and ovulatory function
- Signs of hyperandrogenism
- Glucose and metabolic health
- Cardiovascular risk factors
- Sleep apnea symptoms
- Mental health and emotional well-being
- Fertility and reproductive goals
- Pregnancy-related risks
- Quality of life
- Weight stigma and the patient’s experience of healthcare
The international guideline specifically emphasizes the importance of shared decision-making, emotional well-being, quality of life, and awareness of weight stigma alongside medical management.
There is something else I hope we don’t lose in the science of PMOS: the person experiencing it.
A diagnosis can be technically accurate and still leave a patient feeling confused about various symptoms.
Why are my periods unpredictable?
Why is pregnancy taking longer than expected?
Why am I experiencing changes in my skin or hair?
Why am I being told to lose weight when I came in with a completely different concern?
Why did it take so long for someone to connect these symptoms?
These questions don’t just deserve clinical attention; they challenge identity, lived experience, lifestyle, and personal choices.
The international name-change effort itself involved more than 22,000 survey responses and included people with lived experience, reflecting the recognition that terminology affects how patients understand and experience their condition.
For those of us working in women’s health, that is an important reminder: good care is not only about getting the right diagnosis. It is also about helping someone understand what that diagnosis means for her life.
We get to help them ask and figure out questions like: what about pregnancy?
This is particularly relevant in maternal health.
PMOS doesn’t end when someone becomes pregnant.
The international guideline identifies people with PMOS as having increased risk for certain adverse pregnancy outcomes, making preconception counseling and appropriate pregnancy care important parts of the larger picture.
For maternal-health professionals, this creates an opportunity to think in the long term rather than just putting out fires in the short term.
The conversation should begin long before a positive pregnancy test or even conception preparation.
For someone with PMOS, reproductive health can be part of a much longer-term process for longevity and to experience vitality as a whole life experience:
Adolescence
Menstrual health
Metabolic health
Contraception and fertility
Preconception
Pregnancy
Postpartum health
Long-term health.
That continuum is where maternal health and broader women’s health will meet.
A clinical name change has the potential to change the questions we ask.
Language matters and as well as the words we use when discussing our own bodies, symptoms, experiences. The words and language a clinician also matter as they shape the way we think about our health overall.
When we call it polyendocrine metabolic ovarian syndrome, we are reminded to look at the whole picture as clinicians, educators, and women.
PMOS isn’t just about periods.
It isn’t just about fertility.
It isn’t just about insulin resistance or weight gain or unwanted hair growth.
It is a condition that weaves in discussions on endocrine, metabolic, reproductive, and whole-woman health.
We have a better vision of how we see a condition and the way a woman experiences it. Women have better clarity and confidence discussing a condition that maybe before didn’t fit the mold, but now recognizing it doesn’t have to.
